Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02552368 · ClinicalTrials.gov registry record · NA

Treatment of Chronic Stroke With IpsiHand

A NA study of Stroke, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02552368 is a NA study of Stroke that has completed, run by Washington University School of Medicine. The registered enrollment target is 23 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02552368, a NA study of Stroke, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The ultimate goal of this project is to develop a functioning and clinically feasible method for restoring function to motor-impaired stroke survivors. This ultimate goal will be approached through two different means. The first method is to develop a functioning brain-computer interface that operates based on cortical activity ipsilateral to an intended movement on the motor-impaired side of the body. And secondly, to develop new methods of rehabilitation that involve stimulating peripheral muscles based upon cortical activity ipsilateral to intended movements. Finally, the study seeks to assess changes in functional connectivity as a result of using a BCI device.

Conditions Studied

Interventions

  • DEVICE IpsiHand Device

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2012-08
Est. Completion 2015-11-30
Phase NA

What the Registry Record Tells You About NCT02552368

The ClinicalTrials.gov registry entry for NCT02552368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which IpsiHand Device is the first listed.

NCT02552368 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT02552368 about?

NCT02552368 is a clinical study titled "Treatment of Chronic Stroke With IpsiHand". The ultimate goal of this project is to develop a functioning and clinically feasible method for restoring function to motor-impaired stroke survivors. This ultimate goal will be approached through two different means. The first method is to develop a functioning brain-computer interface that operat...

What is the current status of trial NCT02552368?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2012-08. Estimated completion is 2015-11-30.

What conditions does trial NCT02552368 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT02552368?

The interventions under investigation include: IpsiHand Device (DEVICE).

Who is sponsoring clinical trial NCT02552368?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02552368 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.